11:11 AM EDT, 06/11/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending sharply lower late Tuesday morning, falling 1.34% to 1,420.05 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by telecommunications company VEON (VEON) and pharmaceutical company Ascendis Pharma ( ASND ) , which rose 1.4% and 1.1% respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and biotech firm BioNTech (BNTX), which were up 0.8% and 0.2% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech ( EVAX ) and biopharmaceutical company Genfit ( GNFT ) , which fell 6.3% and 5.4% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and financial services company Banco Santander (SAN), which dropped 2.8% and 2.5% respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Amarin ( AMRN ) , which surged 13.5% and 13.3% respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Autolus Therapeutics ( AUTL ) , which rose 13.3% and 4.3% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies NuCana ( NCNA ) and Verona Pharma ( VRNA ) , which lost 2% and 2.8% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and mining company BHP Group ( BHP ) , which were down 2.2% and 3.1% respectively.